Laloux P, Galanti L, Jamart J
Department of Neurology, Université Catholique de Louvain, Mont-Godinne University Hospital, Yvoir, Belgium.
Acta Neurol Belg. 2004 Mar;104(1):13-9.
In secondary prevention, reduction of the risk of recurrent ischemic stroke might be expected with statins if a correlation can be established between hyperlipidemia and ischemic stroke or some specific ischemic stroke/TIA subtypes. However, such correlation remains controversial, and more particularly with the etiologic stroke/TIA subtypes. Few studies have evaluated the plasma lipid profile in different ischemic stroke subtypes, and notably in lacunar infarctions and cardioembolic strokes. The objectives of this case-control study was to determine (1) which cholesterol fractions is associated with large vessel disease (LVD), small vessel disease (SVD), and cardioembolic disease (CED); (2) whether hypertriglyceridemia is related more to any particular stroke subtype; and (3) whether the lipid profile is different between LVD and SVD which are both responsible for atherothrombotic cerebral ischemia. From a cohort of 485 patients, were selected 240 consecutive cases with ischemic stroke (n = 182) or transient ischemic attack (n = 58) due to a single etiology. The levels of total cholesterol (total-C), LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C), and triglycerides (TG) were measured in 61 patients with LVD, in 65 with SVD, and in 114 with CED, and compared with age- and sex-matched control subjects. Additional analysis was performed to compare the lipid profile between LVD and SVD after adjustment for other risk factors. Compared to controls, the total-C level was significantly higher in patients with SVD (p = 0.005) and LVD (p = 0.018). A significant increase in the LDL-C level (p < 0.004) and a significant decrease in the HDL-C level (p = 0.001) were only observed in the LVD patients. The three stroke subtypes showed higher TG levels than the controls (CED, p = 0.037; SVD, p < 0.001; LVD, p = 0.014). The plasma lipid profile was similar in the SVD and LVD subtypes except for HDL-C, which was significantly lower in LVD than in SVD (p = 0.047). Logistic regression adjusted for confounders showed that decreased HDL-C (p = 0.020), and smoking (p = 0.019) were significant discriminative factors for LVD vs. SVD. In conclusion, this controlled study shows that hypertriglyceridemia is commonly found in patients with ischemic cerebrovascular disease whatever the etiologic subtype, whereas hypercholesterolemia is related more to SVD and LVD. In addition to hypertension and diabetes, hypercholesterolemia may also be involved in the etiology of SVD and differs from LVD by a lower decrease in HDL-C.
在二级预防中,如果能在高脂血症与缺血性卒中或某些特定的缺血性卒中/短暂性脑缺血发作(TIA)亚型之间建立关联,那么使用他汀类药物有望降低复发性缺血性卒中的风险。然而,这种关联仍存在争议,尤其是在病因性卒中/TIA亚型方面。很少有研究评估不同缺血性卒中亚型的血浆脂质谱,特别是腔隙性梗死和心源性栓塞性卒中。本病例对照研究的目的是确定:(1)哪些胆固醇组分与大血管疾病(LVD)、小血管疾病(SVD)和心源性栓塞性疾病(CED)相关;(2)高甘油三酯血症是否与任何特定的卒中亚型更相关;(3)LVD和SVD这两种均导致动脉粥样硬化性脑缺血的疾病,其脂质谱是否不同。从485例患者队列中,连续选取了240例因单一病因导致缺血性卒中(n = 182)或短暂性脑缺血发作(n = 58)的病例。对61例LVD患者、65例SVD患者和114例CED患者测量了总胆固醇(total-C)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)和甘油三酯(TG)水平,并与年龄和性别匹配的对照受试者进行比较。在调整其他危险因素后,对LVD和SVD的脂质谱进行了额外分析以作比较。与对照组相比,SVD患者(p = 0.005)和LVD患者(p = 0.018)的total-C水平显著更高。仅在LVD患者中观察到LDL-C水平显著升高(p < 0.004)和HDL-C水平显著降低(p = 0.001)。三种卒中亚型的TG水平均高于对照组(CED,p = 0.037;SVD,p < 0.001;LVD,p = 0.014)。除HDL-C外,SVD和LVD亚型的血浆脂质谱相似,LVD中的HDL-C显著低于SVD(p = 0.047)。经混杂因素调整的逻辑回归显示,HDL-C降低(p = 0.020)和吸烟(p = 0.019)是LVD与SVD的显著判别因素。总之,这项对照研究表明,无论病因亚型如何,缺血性脑血管疾病患者中普遍存在高甘油三酯血症,而高胆固醇血症与SVD和LVD更相关。除高血压和糖尿病外,高胆固醇血症可能也参与了SVD的病因,并且与LVD的不同之处在于HDL-C降低幅度较小。